STAT News: California Slow on its Stem Cell Clinical Trials Over Last 10 Years
The $3 billion California stem cell agency has been "slow to move" into clinical trials, a major reason it has not yet produced a therapy that is widely available to the public, STAT reported today.
In a lengthy piece on the 12-year-old agency, West Coast editor Charles Piller wrote,
"The National Institutes of Health has supported three and a half times …
Keep reading with a 7-day free trial
Subscribe to The California Stem Cell Report to keep reading this post and get 7 days of free access to the full post archives.